Departamento Bioquimica y Biologia Molecular, Facultad de Farmacia, Universidad de Sevilla, 41012 Seville, Spain.
Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, 41012 Seville, Spain.
Int J Mol Sci. 2021 Sep 8;22(18):9734. doi: 10.3390/ijms22189734.
Microglia play a critical role in both homeostasis and disease, displaying a wide variety in terms of density, functional markers and transcriptomic profiles along the different brain regions as well as under injury or pathological conditions, such as Alzheimer's disease (AD). The generation of reliable models to study into a dysfunctional microglia context could provide new knowledge towards the contribution of these cells in AD. In this work, we included an overview of different microglial depletion approaches. We also reported unpublished data from our genetic microglial depletion model, , in which we temporally controlled microglia depletion by either intraperitoneal (acute model) or oral (chronic model) tamoxifen administration. Our results reported a clear microglial repopulation, then pointing out that our model would mimic a context of microglial replacement instead of microglial dysfunction. Next, we evaluated the origin and pattern of microglial repopulation. Additionally, we also reviewed previous works assessing the effects of microglial depletion in the progression of Aβ and Tau pathologies, where controversial data are found, probably due to the heterogeneous and time-varying microglial phenotypes observed in AD. Despite that, microglial depletion represents a promising tool to assess microglial role in AD and design therapeutic strategies.
小胶质细胞在稳态和疾病中都起着关键作用,其在不同脑区以及损伤或病理条件下(如阿尔茨海默病 (AD))的密度、功能标志物和转录组谱方面表现出广泛的多样性。生成可靠的模型来研究功能失调的小胶质细胞环境可以为这些细胞在 AD 中的作用提供新的知识。在这项工作中,我们包括了对不同小胶质细胞耗竭方法的概述。我们还报告了我们的遗传小胶质细胞耗竭模型的未发表数据,在该模型中,我们通过腹腔内(急性模型)或口服(慢性模型)给予他莫昔芬来暂时控制小胶质细胞耗竭。我们的结果报告了明显的小胶质细胞再增殖,然后指出我们的模型将模拟小胶质细胞替代而不是小胶质细胞功能障碍的情况。接下来,我们评估了小胶质细胞再增殖的起源和模式。此外,我们还回顾了以前评估小胶质细胞耗竭对 Aβ 和 Tau 病理学进展影响的工作,其中发现了有争议的数据,这可能是由于 AD 中观察到的小胶质细胞表型异质性和时变。尽管如此,小胶质细胞耗竭代表了评估 AD 中小胶质细胞作用和设计治疗策略的有前途的工具。